Mónica Sánchez-Cárdenas

Is there a benefit to adding rituximab to CHOP in the overall survival of patients with B-cell non-Hodgkin’s lymphoma in a developing country?

G. Ruiz-Argüelles, D. Gómez-Almaguer, O. Cantú-Rodríguez, 2012, Hematology.

Safety and Cost-Effectiveness of a Simplified Method for Lumbar Puncture in Patients with Hematologic Malignancies

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2014, Acta Haematologica.

Short-term cardiovascular impact and change in the natural history of the disease after high-quality dialysis therapy

H. Pérez-Grovas, Mónica Sánchez-Cárdenas, J. Aceituno-Melgar, 2021 .

High response rate to low‐dose rituximab plus high‐dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2013, European journal of haematology.

Cultural factors related to adherence to imatinib in CML: A Mexican perspective

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2015, Hematology.

The prognostic significance of serum XCL1 concentration in patients with acute lymphoblastic leukemia: a pilot study

D. Gómez-Almaguer, J. Jaime-Pérez, A. Rosas-Taraco, 2017, Annals of Hematology.

Is it time to homogenize the living kidney donation informed consent?

L. Morales-Buenrostro, Abraham Cohen-Bucay, Mónica Sánchez-Cárdenas, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Impact of outpatient non-myeloablative haematopoietic stem cell transplantation in quality of life vs. conventional therapy

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2016, Psychology, health & medicine.

Medication errors: electronic vs. paper-based prescribing. Experience at a tertiary care university hospital.

D. Galarza-Delgado, M. A. Villarreal-Alarcón, J. M. Hinojosa-Amaya, 2016, Journal of evaluation in clinical practice.

Prevalence and Clinical Significance of FLT3 Mutation Status in Acute Myeloid Leukemia Patients: A Multicenter Study.

R. Ortíz-López, D. Gómez-Almaguer, J. Jaime-Pérez, 2016, Archives of medical research.

Posterior reversible encephalopathy syndrome due to malignant hypercalcemia: physiopathological considerations.

D. Galarza-Delgado, M. A. Villarreal-Alarcón, C. Cámara-Lemarroy, 2014, The Journal of clinical endocrinology and metabolism.